Comparison of Inactivated and Oral Poliovirus Vaccines

Introduction: The aim of this study was to compare the rates of systemic and fever reactions of inactivated poliovirus vaccine (IPV) and oral poliovirus vaccine (OPV) at 2, 4, 6 and 18 months of age. Materials and Methods: The study population was made up of 1634 infants at 2, 4, 6, and 18 months o...

Full description

Saved in:
Bibliographic Details
Main Authors: Hüseyin Anıl Korkmaz, Adem Aydın, Belgin Ünal
Format: Article
Language:English
Published: Galenos Publishing House 2013-04-01
Series:Güncel Pediatri
Subjects:
Online Access:http://dx.doi.org/10.4274/Jcp.11.01
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846092674280456192
author Hüseyin Anıl Korkmaz
Adem Aydın
Belgin Ünal
author_facet Hüseyin Anıl Korkmaz
Adem Aydın
Belgin Ünal
author_sort Hüseyin Anıl Korkmaz
collection DOAJ
description Introduction: The aim of this study was to compare the rates of systemic and fever reactions of inactivated poliovirus vaccine (IPV) and oral poliovirus vaccine (OPV) at 2, 4, 6 and 18 months of age. Materials and Methods: The study population was made up of 1634 infants at 2, 4, 6, and 18 months of age who had received IPV and OPV vaccines between 2003 and 2008. All parents reported systemic and fever adverse events to the investigator. Results: Systemic and fever reactions were more commonly observed in infants received OPV vaccines than those received IPV vaccines (2.33% vs. 1.12% and 5.2% vs. 2.8%; p<0.05). Infants received IPV vaccines at 2 months of age had higher rates of systemic reactions than those received IPV vaccines at 4, 6 and 18 months of age (1.8%, 0.77%, 0.67% and 0.62%, respectively; p<0.05). Infants who received IPV vaccines at 4 and 6 months of age had higher fever reactions than those received IPV vaccines at 2 and 18 months of age (1.64%, 3.81%, 3.52% and 0.62%, respectively; p<0.05). Similarly, infants who received OPV vaccines at 2 and 4 month of age had higher systemic and fever reactions than those at 6 and 18 months of age (systemic reactions were 15%, 11.11%, 0.77% and 0.17%, respectively; fever reactions were 27.1%, 24.6%, 2.7% and 1.02%, respectively; p<0.001). Irritability and fever were the most frequently reported reactions. Conclusions: This study showed that IPV had lower rates of adverse events than OPV and emphasized the importance of vaccine adverse event reporting system (Journal of Current Pediatrics 2013; 11: 1-5)
format Article
id doaj-art-be8370c864df4f58b677befd06fb6596
institution Kabale University
issn 1304-9054
language English
publishDate 2013-04-01
publisher Galenos Publishing House
record_format Article
series Güncel Pediatri
spelling doaj-art-be8370c864df4f58b677befd06fb65962025-01-02T20:51:18ZengGalenos Publishing HouseGüncel Pediatri1304-90542013-04-011111510.4274/Jcp.11.01Comparison of Inactivated and Oral Poliovirus VaccinesHüseyin Anıl Korkmaz0Adem Aydın1Belgin Ünal2Dokuz Eylül Üniversitesi Tıp Fakültesi, Çocuk Sağlığı ve Hastalıkları Anabilim Dalı, İzmir, TürkiyeDokuz Eylül Üniversitesi Tıp Fakültesi, Çocuk Sağlığı ve Hastalıkları Anabilim Dalı, Sosyal Pediatri Bilim Dalı, İzmir, TürkiyeDokuz Eylül Üniversitesi Tıp Fakültesi, Halk Sağlığı Anabilim Dalı, İzmir, TürkiyeIntroduction: The aim of this study was to compare the rates of systemic and fever reactions of inactivated poliovirus vaccine (IPV) and oral poliovirus vaccine (OPV) at 2, 4, 6 and 18 months of age. Materials and Methods: The study population was made up of 1634 infants at 2, 4, 6, and 18 months of age who had received IPV and OPV vaccines between 2003 and 2008. All parents reported systemic and fever adverse events to the investigator. Results: Systemic and fever reactions were more commonly observed in infants received OPV vaccines than those received IPV vaccines (2.33% vs. 1.12% and 5.2% vs. 2.8%; p<0.05). Infants received IPV vaccines at 2 months of age had higher rates of systemic reactions than those received IPV vaccines at 4, 6 and 18 months of age (1.8%, 0.77%, 0.67% and 0.62%, respectively; p<0.05). Infants who received IPV vaccines at 4 and 6 months of age had higher fever reactions than those received IPV vaccines at 2 and 18 months of age (1.64%, 3.81%, 3.52% and 0.62%, respectively; p<0.05). Similarly, infants who received OPV vaccines at 2 and 4 month of age had higher systemic and fever reactions than those at 6 and 18 months of age (systemic reactions were 15%, 11.11%, 0.77% and 0.17%, respectively; fever reactions were 27.1%, 24.6%, 2.7% and 1.02%, respectively; p<0.001). Irritability and fever were the most frequently reported reactions. Conclusions: This study showed that IPV had lower rates of adverse events than OPV and emphasized the importance of vaccine adverse event reporting system (Journal of Current Pediatrics 2013; 11: 1-5)http://dx.doi.org/10.4274/Jcp.11.01Inactivated poliovirus vaccineoral poliovirus vaccinevaccinesinfants
spellingShingle Hüseyin Anıl Korkmaz
Adem Aydın
Belgin Ünal
Comparison of Inactivated and Oral Poliovirus Vaccines
Güncel Pediatri
Inactivated poliovirus vaccine
oral poliovirus vaccine
vaccines
infants
title Comparison of Inactivated and Oral Poliovirus Vaccines
title_full Comparison of Inactivated and Oral Poliovirus Vaccines
title_fullStr Comparison of Inactivated and Oral Poliovirus Vaccines
title_full_unstemmed Comparison of Inactivated and Oral Poliovirus Vaccines
title_short Comparison of Inactivated and Oral Poliovirus Vaccines
title_sort comparison of inactivated and oral poliovirus vaccines
topic Inactivated poliovirus vaccine
oral poliovirus vaccine
vaccines
infants
url http://dx.doi.org/10.4274/Jcp.11.01
work_keys_str_mv AT huseyinanılkorkmaz comparisonofinactivatedandoralpoliovirusvaccines
AT ademaydın comparisonofinactivatedandoralpoliovirusvaccines
AT belginunal comparisonofinactivatedandoralpoliovirusvaccines